CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 37 filers reported holding CORREVIO PHARMA CORP in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $0 | – | 9 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SUMMER ROAD LLC | 250,000 | $103,000 | 0.68% |
| Tamarack Advisers, LP | 2,500,000 | $1,019,000 | 0.23% |
| Virtu Financial LLC | 287,972 | $118,000 | 0.01% |
| ARS Investment Partners, LLC | 147,818 | $61,000 | 0.01% |
| Pacifica Partners Inc. | 2,665 | $1,000 | 0.00% |
| OXFORD ASSET MANAGEMENT LLP | 116,653 | $48,000 | 0.00% |
| K.J. Harrison & Partners Inc | 12,860 | $5,000 | 0.00% |
| TORONTO DOMINION BANK | 153 | $0 | 0.00% |
| SCOTIA CAPITAL INC. | 19,000 | $8,000 | 0.00% |
| MORGAN STANLEY | 99,852 | $41,000 | 0.00% |